Panbio登革熱抗原檢測(cè)卡

廣州健侖生物科技有限公司

本公司為大家供應(yīng)各種進(jìn)口品牌登革熱檢測(cè)試劑盒，包括澳洲Panbio、美國(guó)NovaBios、美國(guó)CORTEZ等美國(guó)CDC品牌。主要包括膠體金、酶免、PCR等方法學(xué)。歡迎咨詢

Panbio Dengue Early ELISA 

非洲工作用登革熱試紙

熱帶國(guó)家旅游用登革熱檢測(cè)試紙

登革熱IgM抗體、登革熱IgG抗體、登革熱NS1抗原、登革熱早期檢測(cè)試劑盒

登革熱核酸檢測(cè)試劑盒

Panbio公司簡(jiǎn)介:
1、1988年成立，2001年在澳大利亞證券交易所上市。
2、Panbio系關(guān)于蟲(chóng)媒感染性疾病及熱帶感染性疾病的專業(yè)供貨商。
3、產(chǎn)品面向蟲(chóng)媒感染性疾病的檢測(cè)，在國(guó)內(nèi)疾控系統(tǒng)具有*的認(rèn)知和認(rèn)可度。
4、2010年銷售800萬(wàn)檢測(cè)試劑，為30多種疾病提供診斷。

Panbio登革熱介紹：

1、登革熱快速檢測(cè)試劑(Dengue Duo Cassette R-DEN03D)
用于定性的快速檢測(cè)人群血清、血漿或全血中登革病毒的IgM及IgG抗體。可在15分鐘內(nèi)檢測(cè)結(jié)果。

2、登革IgM捕捉ELISA(Dengue IgM Capture ELISA E-DEN01M)
用于定性的檢測(cè)人群血清中登革病毒的IgM抗體，用于臨床實(shí)驗(yàn)室對(duì)具有持續(xù)發(fā)燒的登革熱癥狀的病人的輔助診斷。

3、登革IgG捕捉ELISA(Dengo IgG Capture ELISA E-DEN02G)
用于定性檢測(cè)血清中登革病毒(血清型1、2、3及4型)的IgG抗體。用于臨床實(shí)驗(yàn)室對(duì)繼發(fā)登革熱感染的輔助診斷。

4、登革早期ELISA(Dengue Early ELISA E-DEN01P)
用于定性檢測(cè)血清中登革病毒的NS1抗原(血清型1、2、3及4型)。用于臨床實(shí)驗(yàn)室對(duì)有持續(xù)發(fā)燒的登革熱癥狀病人的輔助性診斷。

5、登革IgG間接ELISA(Dengue IgG Indirect ELISA E-DEN01G)
用于定性檢測(cè)血清中登革病毒(血清型1、2、3及4型)的IgG抗體，用于臨床實(shí)驗(yàn)室對(duì)具有持續(xù)發(fā)燒的登革感染癥狀或接觸史的患者的輔助性診斷。

6、登革IgM & IgG聯(lián)檢ELISA(Dengue Duo IgM & IgG Capture ELISA E-DEN01D)
用于定性檢測(cè)血清中登革病毒的IgM和IgG抗體。可以區(qū)分原發(fā)感染與繼發(fā)感染。

Dengue產(chǎn)品介紹

Panbio登革熱抗原檢測(cè)卡

哪里會(huì)爆發(fā)登革熱？
登革熱疫情主要發(fā)生在Ae地區(qū)。埃及伊蚊（有時(shí)也是白紋伊蚊）蚊子住。這包括世界上大多數(shù)熱帶城市地區(qū)。登革熱病毒可能會(huì)在訪問(wèn)登革熱普遍存在的熱帶地區(qū)的同時(shí)被感染的旅客引入。
可以做些什么來(lái)降低登革熱的風(fēng)險(xiǎn)？
沒(méi)有預(yù)防登革熱的疫苗。居住在艾滋病感染地區(qū)的居民的比較好預(yù)防措施。埃及是為了消除蚊子放置雞蛋的地方，主要是裝有水的人造容器。
收集雨水或儲(chǔ)存水的物品（例如塑料容器，55加侖桶，桶或二手汽車輪胎）應(yīng)被覆蓋或妥善丟棄。寵物和動(dòng)物澆水容器和鮮花花瓶應(yīng)每周至少清空一次清潔（清除雞蛋）。這樣可以消除蚊子和幼蟲(chóng)，并減少這些地區(qū)存在的蚊子數(shù)量。
使用空調(diào)或窗戶和門窗降低蚊子進(jìn)入室內(nèi)的風(fēng)險(xiǎn)。適當(dāng)應(yīng)用含有20％至30％DEET的驅(qū)蚊劑作為暴露皮膚和衣服的活性成分，會(huì)降低被蚊子咬傷的危險(xiǎn)。旅客的登革熱感染風(fēng)險(xiǎn)似乎很小。如果疫情正在進(jìn)行中，或者游客在沒(méi)有空調(diào)或篩選門窗的情況下進(jìn)入住房，風(fēng)險(xiǎn)會(huì)增加。
如何預(yù)防登革熱出血熱（DHF）的流行？
預(yù)防登革熱的重點(diǎn)是可持續(xù)的，社區(qū)的，綜合的蚊子控制，對(duì)殺蟲(chóng)劑（化學(xué)殺螨劑和殺生物劑）的依賴程度有限。預(yù)防流行病需要協(xié)調(diào)*的社區(qū)努力，提高對(duì)登革熱/ DHF的認(rèn)識(shí)，如何識(shí)別，以及如何控制傳播蚊子的信息。居民有責(zé)任保持院子和庭院免受可以生產(chǎn)蚊子的積水。
登革熱更新是一系列關(guān)于登革熱的報(bào)告。我們的目的是為您提供預(yù)防登革熱努力的簡(jiǎn)明扼要的更新，特別是疾病控制和預(yù)防中心（CDC）在這些努力中所起的作用。
2010年登革熱病例在佛羅里達(dá)南部的部分地區(qū)，波多黎各和美屬維爾京群島（USVI）的美國(guó)地區(qū)達(dá)到歷史zui高水平，使登革熱更加接近家鄉(xiāng)。中美洲和南美洲也受到同樣的折磨。波多黎各歷*發(fā)生了zui大的爆發(fā)（圖1），記錄了21,000多起病例。
2010年：PUERTO RICO歷*zui大的*
2010年登革熱病例在佛羅里達(dá)南部的部分地區(qū)，波多黎各和美屬維爾京群島（USVI）的美國(guó)地區(qū)達(dá)到歷史zui高水平，使登革熱更加接近家鄉(xiāng)。中美洲和南美洲也受到同樣的折磨。波多黎各歷*發(fā)生了zui大的爆發(fā)（圖1），記錄了21,000多起病例。
報(bào)告病例約75％可以實(shí)驗(yàn)室證實(shí)，由于輕度病例經(jīng)常未報(bào)告，發(fā)病率可能至少高出幾倍。全島報(bào)告病例，西北地區(qū)病例發(fā)病率zui高。
在確診病例中，多數(shù)為登革1或登革熱4;發(fā)現(xiàn)相對(duì)較少的登革熱病例2。以前的重大疫情只發(fā)生在三年前，2007年有報(bào)告超過(guò)10,500例。
2009年佛羅里達(dá)州報(bào)告說(shuō)，在西區(qū)老城區(qū)，75年來(lái)*局部登革熱傳播。居民血清調(diào)查顯示感染率為5％，表明嚴(yán)重的傳播風(fēng)險(xiǎn)。盡管縣，縣在2010年初進(jìn)行了*的管理工作，但截至2010年底，佛羅里達(dá)又報(bào)告了65例本地登革熱病例。所有案件都在西嶼，除了兩個(gè)縣以外的兩個(gè)縣。當(dāng)?shù)匦l(wèi)生防蚊官員正在評(píng)估下個(gè)季節(jié)的戰(zhàn)略。登革熱自19世紀(jì)初以來(lái)一直是USVI的復(fù)發(fā)性公共衛(wèi)生問(wèn)題，包括過(guò)去六年的三年。 2010年期間，至少有100例疑似病例和30例實(shí)驗(yàn)室確診病例報(bào)告。隨著流行病潛力的變化，USVI衛(wèi)生署在疾病預(yù)防控制中心的幫助下，開(kāi)展了公共和衛(wèi)生保健提供者的教育運(yùn)動(dòng)，并在全國(guó)范圍內(nèi)增加了蚊子防治措施。
這些例子突出了登革熱和基孔肯雅病毒對(duì)美國(guó)地區(qū)的潛在威脅，蚊子載體Ae。埃及和埃及。白斑病發(fā)生。我們描述下面基孔肯雅的新興威脅。

Panbio

我司還提供其它進(jìn)口或國(guó)產(chǎn)試劑盒：登革熱、瘧疾、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲(chóng)病、違禁品濫用、肺炎球菌、軍團(tuán)菌等試劑盒以及日本生研細(xì)菌分型診斷血清、德國(guó)SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

想了解更多的Panbio產(chǎn)品及服務(wù)請(qǐng)掃描下方二維碼：

【公司名稱】 廣州健侖生物科技有限公司
【市場(chǎng)部】    楊永漢

【】 
【騰訊  】 2042552662
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號(hào)二期2幢101-103室

references：

Where can outbreaks of dengue occur?
Outbreaks of dengue occur primarily in areas where Ae. aegypti (sometimes also Ae. albopictus) mosquitoes live. This includes most tropical urban areas of the world. Dengue viruses may be introduced into areas by travelers who become infected while visiting other areas of the tropics where dengue commonly exists.
What can be done to reduce the risk of acquiring dengue?
There is no vaccine for preventing dengue. The best preventive measure for residents living in areas infested with Ae. aegypti is to eliminate the places where the mosquito lays her eggs, primarily artificial containers that hold water.
Items that collect rainwater or to store water (for example, plastic containers, 55-gallon drums, buckets, or used auto tires) should be covered or properly discarded. Pet and animal watering containers and vases with fresh flowers should be emptied and cleaned (to remove eggs) at least once a week. This will eliminate the mosquito eggs and larvae and reduce the number of mosquitoes present in these areas.
Using air conditioning or window and door screens reduces the risk of mosquitoes coming indoors. Proper application of mosquito repellents containing 20% to 30% DEET as the active ingredient on exposed skin and clothing decreases the risk of being bitten by mosquitoes. The risk of dengue infection for international travelers appears to be small. There is increased risk if an epidemic is in progress or visitors are in housing without air conditioning or screened windows and doors.
How can we prevent epidemics of dengue hemorrhagic fever (DHF)?
The emphasis for dengue prevention is on sustainable, community-based, integrated mosquito control, with limited reliance on insecticides (chemical larvicides, and adulticides). Preventing epidemic disease requires a coordinated community effort to increase awareness about dengue fever/DHF, how to recognize it, and how to control the mosquito that transmits it. Residents are responsible for keeping their yards and patios free of standing water where mosquitoes can be produced.
The Dengue Update is a series of reports on dengue. Our purpose is to provide you with concise, informative updates on global efforts to prevent dengue, and particularly the role the Centers for Disease Control and Prevention (CDC) plays in those efforts.
Dengue cases reached historically high levels in 2010 in parts of southern Florida, and in the US territories of Puerto Rico and the US Virgin Islands (USVI), bringing the global dengue resurgence even closer to home. Central and South America were similarly afflicted. Puerto Rico experienced the largest outbreak in its history (Figure 1), recording over 21,000 reported cases.
2010: LARGEST DENGUE OUTBREAK IN PUERTO RICO HISTORY
Dengue cases reached historically high levels in 2010 in parts of southern Florida, and in the US territories of Puerto Rico and the US Virgin Islands (USVI), bringing the global dengue resurgence even closer to home. Central and South America were similarly afflicted. Puerto Rico experienced the largest outbreak in its history (Figure 1), recording over 21,000 reported cases.
About 75% of the reported cases could be laboratory confirmed and, because mild cases are often not reported, the incidence was probably at least several times higher. Cases were reported throughout the island, with highest incidence in the northwestern region.
Among confirmed cases the majority were either dengue 1 or dengue 4; relatively-few cases of dengue 2 were found. The previous major epidemic occurred only three years earlier, in 2007 when more than 10,500 cases were reported.
In 2009, Florida reported the first cases of local dengue transmission in 75 years, within Old Town, Key West. A serosurvey of residents suggested an infection rate of 5%, indicating serious risk of transmission. Despite thorough control efforts carried out by the county and state in early 2010, by the end of 2010, Florida had reported an additional 65 locally acquired dengue cases. All the cases were in Key West, except two cases in two more northerly counties. Local health and mosquito control officials are now assessing strategies for the coming season. Dengue has been a reoccurring public health problem for the USVI since the early 1800s, including in three of the past six years. During 2010, at least 100 suspected and 30 laboratory confirmed cases have been reported. As the epidemic potential became clear, the USVI Department of Health, with help from CDC, conducted public and health care provider education campaigns and increased mosquito control measures throughout the territory.
These examples highlight the potential threat of dengue and chikungunya viruses to regions of the US where mosquito vectors, Ae. aegypti and Ae. albopictus occur. We describe the emerging threat of chikungunya below.